Article info

Original research
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

Authors

  1. Correspondence to Lillian Siu; lillian.siu{at}uhn.ca
View Full Text

Citation

Siu L, Brody J, Gupta S, et al
Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

Publication history

  • Accepted August 23, 2020
  • First published October 9, 2020.
Online issue publication 
October 09, 2020
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.